Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10886286 | 0.97 | KDM4E (0.30) | KDM4EPOLBL3MBTL1 | |
| Triphenylene SCHEMBL2462849 | 0.91 | — | — | |
| Water SCHEMBL28882526 | 0.69 | — | — | |
| SCHEMBL10878212 | 0.66 | SLC6A2 (0.30) | — | |
| SCHEMBL10473761 | 0.65 | — | — | |
| SCHEMBL2186053 | 0.62 | NOS3 (0.33) | — | |
| SCHEMBL21176634 | 0.62 | — | — | |
| SCHEMBL157368 | 0.62 | — | — | |
| SCHEMBL6247033 | 0.61 | — | — | |
| SCHEMBL2016299 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11254687-B2 | Organic light-emitting material and manufacturing method thereof, and organic light-emitting device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2022-02-22 | — | — | US | claimed |
| US-20210403481-A1 | ORGANIC LIGHT-EMITTING MATERIAL AND MANUFACTURING METHOD THEREOF, AND ORGANIC LIGHT-EMITTING DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-12-30 | — | — | US | claimed |
| US-20180072863-A1 | METHOD OF MAKING GRAPHENE COMPOSITIONS | VORBECK MATERIALS CORP. (US) | 2018-03-15 | — | — | US | claimed |
| EP-2365951-B1 | PROCESSES FOR PREPARING TRIPHENYLENE | ALBEMARLE CORP (US) | 2014-01-29 | — | — | EP | claimed |
| US-8575412-B2 | Processes for preparing triphenylene | ALBEMARLE CORPORATION (US) | 2013-11-05 | — | — | US | claimed |
| US-20110301395-A1 | Processes for Preparing Triphenylene | ALBEMARLE CORPORATION (US) | 2011-12-08 | — | — | US | claimed |
| EP-2365951-A2 | PROCESSES FOR PREPARING TRIPHENYLENE | Albemarle Corporation (US) | 2011-09-21 | — | — | EP | claimed |
| WO-2010065216-A2 | PROCESSES FOR PREPARING TRIPHENYLENE | ALBEMARLE CORPORATION (US) | 2010-06-10 | — | — | WO | claimed |
| US-20080014496-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERIES AND DEVICES USING THE SAME | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2008-01-17 | — | — | US | claimed |
| EP-1215745-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY CELL AND DEVICE USING THE SAME | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-06-19 | — | — | EP | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| JP-60166384-A | — | — | None | — | — | JP | disclosed |
| US-20220241764-A1 | CATALYST COMPOSITION AND PROCESS FOR OLIGOMERIZATION OF ETHYLENE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-08-04 | — | — | US | disclosed |
| US-11254687-B2 | Organic light-emitting material and manufacturing method thereof, and organic light-emitting device | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2022-02-22 | — | — | US | disclosed |
| US-20210403481-A1 | ORGANIC LIGHT-EMITTING MATERIAL AND MANUFACTURING METHOD THEREOF, AND ORGANIC LIGHT-EMITTING DEVICE | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-12-30 | — | — | US | disclosed |
| US-4473704-A | ANALGESICS, ANTIEMETICS | PFIZER INC. (US) | 1984-09-25 | — | — | US | disclosed |
| US-4473704-A | ANALGESICS, ANTIEMETICS | PFIZER INC. (US) | 1984-09-25 | — | — | US | disclosed |
| EP-0090526-A1 | Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta(1)phenanthrenes, decahydro-1H-pyrido(1,2-f)phenanthridines and decahydropyrrolo(1,2-f)phenanthridines as CNS agents | PFIZER INC. (US) | 1983-10-05 | — | — | EP | disclosed |
| EP-0090526-A1 | Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta(1)phenanthrenes, decahydro-1H-pyrido(1,2-f)phenanthridines and decahydropyrrolo(1,2-f)phenanthridines as CNS agents | PFIZER INC. (US) | 1983-10-05 | — | — | EP | disclosed |
| EP-0090516-A1 | Substituted hexahydropyrrolo(1,2-a)-quinoline, hexahydro-1H-pyrido(1,2-a)-quinoline, hexahydrobenzo(3)indene and octahydrophenanthrene CNS agents | PFIZER INC. (US) | 1983-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254687-B2 | Organic light-emitting material and manufacturing method thereof, and organic light-emitting device | CYBA, SLC43A1, ABCB1 | KDM4E 2011/4885POLB 1473/4885L3MBTL1 407/4885 |
| US-20220241764-A1 | CATALYST COMPOSITION AND PROCESS FOR OLIGOMERIZATION OF ETHYLENE | XRN2, XRCC6, TRRAP | KDM4E 4246/4885POLB 715/4885L3MBTL1 3105/4885 |
| US-20110301395-A1 | Processes for Preparing Triphenylene | TPR, DHCR24, TERT | KDM4E 2979/4885POLB 35/4885L3MBTL1 1559/4885 |
| US-20210403481-A1 | ORGANIC LIGHT-EMITTING MATERIAL AND MANUFACTURING METHOD THEREOF, AND ORGANIC LIGHT-EMITTING DEVICE | CYBA, SLC43A1, ABCB1 | KDM4E 2011/4885POLB 1473/4885L3MBTL1 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.